Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit

被引:113
作者
Horisawa, E
Hirota, T
Kawazoe, S
Yamada, J
Yamamoto, H
Takeuchi, H
Kawashima, Y
机构
[1] Maruho Co Ltd, Pharmaceut Res Labs, Shiga 5220201, Japan
[2] Gifu Pharmaceut Univ, Dept Pharmaceut Engn, Gifu 5020003, Japan
基金
日本学术振兴会;
关键词
PLGA nanosphere; emulsion solvent diffusion method; intra-articular delivery system; antigen-induced arthritis; prolonged anti-inflammatory action;
D O I
10.1023/A:1015123024113
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The objective of the present study was to develop prolonged anti-inflammatory action of DL-lactide/glycolide copolymer (PLGA) nanosphere incorporating a water-soluble corticosteroid (betamethasone sodium phosphate; BSP). Another aim was to demonstrate the biocompatibility and biologic efficacy of these BSP-loaded nanospheres directly administered into ovalbumin-induced chronic synovitis in the rabbit. Methods. BSP-loaded nanospheres were prepared by an emulsion solvent diffusion method in oil (caprylate and caprate triglyceride). The drug releasing properties of the nanospheres were measured in vitro in phosphate buffer saline (PBS: pH7.4), and in vivo in rat air-pouch (pseudo synovial fluid). The BSP-loaded nanosphere suspensions were administered into the joint cavity in a model of antigen-induced arthritic rabbit and evaluated by measuring the joint swelling, and the biocompatibility was appraised by histologic microscopy. Results. The BSP-nanospheres were a unimodally-dispersed particulate system with a mean diameter ranging from 300 to 490 nm, and BSP was efficiently entrapped in the lipophilic copolymer (PLGA), although its hydrophilic properties. The drug release-rate from the nanospheres in PBS was controlled by the molecular weight and the lactic/glycolic acid (LA/GA) ratio of the polymers. The in vitro releasing study demonstrated that sustained drug release occurred for over three weeks. In the antigen-induced arthritic rabbit, the joint swelling decreased significantly by administering BSP-loaded nanospheres during a 21-day period after intra-articular challenge. With regards to the prolonged anti-inflammatory efficacy, serum antibody to ovalbumin showed a sustained reduction during the period, and the steroidal effect appeared by the degradation of the polymer in the synovium. The BSP-nanosphere administered was phagocytosed by the synovial activated-cells and the cartilage degradation was almost prevented. Conclusions. Direct intra-articular injection of a PLGA nanosphere system with a water-soluble steroid provided a prolonged pharmacological efficacy in the joints of arthritic rabbits. The local anesthetic in the knee-joints was evaluated to be safe and without biologic damage.
引用
收藏
页码:403 / 410
页数:8
相关论文
共 35 条
[1]  
BLACKHAM A, 1991, CLIN EXP IMMUNOL, V86, P224
[2]  
Brown KE, 1998, ARTHRITIS RHEUM, V41, P2185, DOI 10.1002/1529-0131(199812)41:12<2185::AID-ART13>3.0.CO
[3]  
2-C
[4]   POTENTIAL USE OF ALBUMIN MICROSPHERES AS A DRUG DELIVERY SYSTEM .2. INVIVO DEPOSITION AND RELEASE OF STEROIDS [J].
BURGESS, DJ ;
DAVIS, SS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 46 (1-2) :69-76
[5]   POTENTIAL USE OF ALBUMIN MICROSPHERES AS A DRUG DELIVERY SYSTEM .1. PREPARATION AND INVITRO RELEASE OF STEROIDS [J].
BURGESS, DJ ;
DAVIS, SS ;
TOMLINSON, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 39 (1-2) :129-136
[6]   Preparation and testing of cyclosporine microsphere and solution formulations in the treatment of polyarthritis in rats [J].
D'Souza, M ;
DeSouza, P .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (09) :841-852
[7]   Macrophage depletion by albumin microencapsulated clodronate: Attenuation of cytokine release in macrophage-dependent glomerulonephritis [J].
D'Souza, MJ ;
Oettinger, CW ;
Shah, A ;
Tipping, PG ;
Huang, XR ;
Milton, GV .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (05) :591-596
[8]   PHARMACOKINETICS AND PHARMACODYNAMICS OF GLUCOCORTICOID SUSPENSIONS AFTER INTRAARTICULAR ADMINISTRATION [J].
DERENDORF, H ;
MOLLMANN, H ;
GRUNER, A ;
HAACK, D ;
GYSELBY, G .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (03) :313-317
[9]   NOVEL TREATMENT FOR JOINT INFLAMMATION [J].
DINGLE, JT ;
GORDON, JL ;
HAZLEMAN, BL ;
KNIGHT, CG ;
THOMAS, DPP ;
PHILLIPS, NC ;
SHAW, IH ;
FILDES, FJT ;
OLIVER, JE ;
JONES, G ;
TURNER, EH ;
LOWE, JS .
NATURE, 1978, 271 (5643) :372-373
[10]  
DUMONDE DC, 1962, BRIT J EXP PATHOL, V43, P373